These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 24978907)

  • 1. Development of an intravitreal peptide (BQ123) sustained release system based on poly(2-hydroxyoctanoic acid) aiming at a retinal vasodilator response.
    Veurink M; Mangioris G; Kaufmann B; Asmus L; Hennig M; Heiligenhaus A; Gurny R; Möller M; Pournaras CJ
    J Ocul Pharmacol Ther; 2014 Aug; 30(6):517-23. PubMed ID: 24978907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and in vitro assessment of L-lactic acid-based copolymers as prodrug and carrier for intravitreal sustained L-lactate release to reverse retinal arteriolar occlusions.
    Veurink M; Asmus L; Hennig M; Kaufmann B; Bagnewski L; Heiligenhaus A; Mendrinos E; Pournaras CJ; Gurny R; Möller M
    Eur J Pharm Sci; 2013 May; 49(2):233-40. PubMed ID: 23500039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An injectable thermosensitive polymeric hydrogel for sustained release of Avastin® to treat posterior segment disease.
    Xie B; Jin L; Luo Z; Yu J; Shi S; Zhang Z; Shen M; Chen H; Li X; Song Z
    Int J Pharm; 2015 Jul; 490(1-2):375-83. PubMed ID: 26027491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled Release of Dexamethasone From an Intravitreal Delivery System Using Porous Silicon Dioxide.
    Hou H; Wang C; Nan K; Freeman WR; Sailor MJ; Cheng L
    Invest Ophthalmol Vis Sci; 2016 Feb; 57(2):557-66. PubMed ID: 26882530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative MR imaging study of intravitreal sustained release of VEGF in rabbits.
    Alikacem N; Yoshizawa T; Nelson KD; Wilson CA
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1561-9. PubMed ID: 10798677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
    Duvvuri S; Janoria KG; Pal D; Mitra AK
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular Biodistribution of Spironolactone after a Single Intravitreal Injection of a Biodegradable Sustained-Release Polymer in Rats.
    Dahmana N; Kowalczuk L; Gabriel D; Behar-Cohen F; Gurny R; Kalia YN
    Mol Pharm; 2020 Jan; 17(1):59-69. PubMed ID: 31751144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerability and pharmacokinetics of intravitreal sirolimus.
    Mudumba S; Bezwada P; Takanaga H; Hosoi K; Tsuboi T; Ueda K; Kawazu K; Ali Y; Naor J
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):507-14. PubMed ID: 22662868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained intravitreal delivery of connexin43 mimetic peptide by poly(D,L-lactide-co-glycolide) acid micro- and nanoparticles--Closing the gap in retinal ischaemia.
    Chen YS; Green CR; Wang K; Danesh-Meyer HV; Rupenthal ID
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):378-86. PubMed ID: 25497487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intravitreal drug delivery by microspheres of biodegradable polymers].
    Moritera T; Ogura Y; Honda Y; Wada R; Hyon SH; Ikada Y
    Nippon Ganka Gakkai Zasshi; 1990 May; 94(5):508-13. PubMed ID: 2220493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The vasodilatory effect of juxta-arteriolar microinjection of endothelinA receptor inhibitor in healthy and acute branch retinal vein occlusion minipig retinas.
    Stangos AN; Petropoulos IK; Pournaras JA; Mendrinos E; Pournaras CJ
    Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2185-90. PubMed ID: 19875661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preliminary evaluation of dexamethasone palmitate emulsion: a novel intravitreal sustained delivery of corticosteroid for treatment of macular edema.
    Daull P; Paterson CA; Kuppermann BD; Garrigue JS
    J Ocul Pharmacol Ther; 2013 Mar; 29(2):258-69. PubMed ID: 23331052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal l-Arginine injection reverses the retinal arteriolar vasoconstriction that occurs after experimental acute branch retinal vein occlusion.
    Mendrinos E; Petropoulos IK; Mangioris G; Papadopoulou DN; Pournaras CJ
    Exp Eye Res; 2010 Aug; 91(2):205-10. PubMed ID: 20457153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
    Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
    Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injectable formulations for an intravitreal sustained-release application of a novel single-chain VEGF antibody fragment.
    Asmus LR; Grimshaw JP; Richle P; Eicher B; Urech DM; Gurny R; Möller M
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):250-60. PubMed ID: 25779352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal delivery of oligonucleotides by sterically stabilized liposomes.
    Bochot A; Fattal E; Boutet V; Deverre JR; Jeanny JC; Chacun H; Couvreur P
    Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):253-9. PubMed ID: 11773039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of vitreous clearance and potential retinal toxicity of intravitreal lornoxicam (xefo).
    Diakonis VF; Tsourdou A; Tzatzarakis MN; Tsika C; Charisis S; Naoumidi I; Plainis S; Tsilimbaris MK
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):627-32. PubMed ID: 23556534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel design of one-side coated biodegradable intrascleral implant for the sustained release of triamcinolone acetonide.
    Kim YM; Lim JO; Kim HK; Kim SY; Shin JP
    Eur J Pharm Biopharm; 2008 Sep; 70(1):179-86. PubMed ID: 18667297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of kallidinogenase on ischemic changes induced by repeated intravitreal injections of endothelin-1 in rabbit retina.
    Nagano H; Wei PZ; Wen CQ; Jomori T; Oku H; Ikeda T; Saito Y; Tano Y
    Curr Eye Res; 2007 Feb; 32(2):113-22. PubMed ID: 17364744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin-1 action via endothelin receptors is a primary mechanism modulating retinal circulatory response to hyperoxia.
    Takagi C; King GL; Takagi H; Lin YW; Clermont AC; Bursell SE
    Invest Ophthalmol Vis Sci; 1996 Sep; 37(10):2099-109. PubMed ID: 8814149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.